Cargando…
Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial
BACKGROUND: Cerebral cavernous malformations (CCMs) are vascular malformations characterized by clusters of enlarged leaky capillaries in the central nervous system. They may result in intracranial haemorrhage, epileptic seizure(s), or focal neurological deficits, and potentially lead to severe disa...
Autores principales: | Lanfranconi, Silvia, Scola, Elisa, Bertani, Giulio Andrea, Zarino, Barbara, Pallini, Roberto, d’Alessandris, Giorgio, Mazzon, Emanuela, Marino, Silvia, Carriero, Maria Rita, Scelzo, Emma, Faragò, Giuseppe, Castori, Marco, Fusco, Carmela, Petracca, Antonio, d’Agruma, Leonardo, Tassi, Laura, d’Orio, Piergiorgio, Lampugnani, Maria Grazia, Nicolis, Enrico Bjorn, Vasamì, Antonella, Novelli, Deborah, Torri, Valter, Meessen, Jennifer Marie Theresia Anna, Salman, Rustam Al-Shahi, Dejana, Elisabetta, Latini, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218540/ https://www.ncbi.nlm.nih.gov/pubmed/32398113 http://dx.doi.org/10.1186/s13063-020-4202-x |
Ejemplares similares
-
Genetic analysis of genes associated with epilepsy
por: Guerri, Giulia, et al.
Publicado: (2020) -
Biomarkers for glioblastoma multiforme: status quo
por: Montano, Nicola, et al.
Publicado: (2016) -
Neuromodulation for Brain Tumors: Myth or Reality? A Narrative Review
por: D’Alessandris, Quintino Giorgio, et al.
Publicado: (2023) -
Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice
por: Ceruti, Tommaso, et al.
Publicado: (2022) -
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome
por: Cesarini, Valeriana, et al.
Publicado: (2017)